Biosensor-Based Active Ingredients Recognition System for Screening STAT3 Ligands from Medical Herbs

Abstract

A surface plasmon resonance (SPR) biosensor-based active ingredients recognition system (SPR-AIRS) was developed, validated, and applied to screen signal transducer and activator of transcription 3 (STAT3) ligands. First, features of the screening system were investigated in four aspects: (1) specificity of the STAT3-immobilized chip, it shows that the chip could be applied to screen STAT3 ligands from complex mixture; (2) linearity and limit of detection (LOD) of the system, the minimum recovery cycle number was determined as 5 cycles; (3) saturability of the chip, the results indicate that it is necessary to select a proper concentration based on the compound's K value; (4) robustness of the system, it indicates that inactive compounds in the matrix could not interfere with active compounds in the process of screening. Next, SPR-AIRS was applied to screen STAT3 ligands from medicinal herbs. Nine candidate compounds were fished out. Then SPR assay and molecular docking were performed to verify the interplay between STAT3 and candidate compounds. Apoptosis assay and luciferase report assay were performed to investigate the drug effect of candidate compounds on STAT3 activity. Western blot results indicated that neobaicalein and polydatin could inhibit the phosphorylation of STAT3. As far as we know, this is the first time that neobaicalein and polydatin are reported as effective STAT3 ligands. In a conclusion, we have systemically demonstrated the feasibility of SPR biosensor-based screening method applying to complex drug systems, and our findings suggest that SPR-AIRS could be a sensitive and effective solution for the discovery of active compounds from a complex matrix.

Identifying potential anti-COVID-19 pharmacological components of traditional Chinese medicine Lianhuaqingwen capsule based on human exposure and ACE2 biochromatography screening

“…S4A–S4E . According to the general criteria 31 , the situation of R max value exceeding 2 times of the response of compounds should be considered as nonspecific binding ligands. As shown in Table 1 , the R max values of all positive components were less than 25 RU, conforming to the characteristic of specific binding.…”

Surface plasmon resonance based analysis of the binding of LYAR protein to the rs368698783 (G>A) polymorphic Aγ-globin gene sequences mutated in β-thalassemia

“…The results presented in this study are relevant not only from the theoretical viewpoint but might also be of interest in applied pharmacology. The method developed and validated here might be used for the screening of drugs able to inhibit LYAR-DNA interactions, thereby activating γ-globin gene transcription, as done with SPR-BIA in different experimental systems [46][47][48][49]. In this context, SPR-BIA has been extensively used in studies focused on the effects of low molecular weight drugs able to interfere with protein-DNA interaction.…”

Rifapentine is an entry and replication inhibitor against yellow fever virus both in vitro and in vivo

“…The synthesized and purified viral proteins were immobilized to a CM5 Series S sensor chip (GE, United States). The carboxylic groups of the chip were activated by EDC 0.2 M and NHS 0.05 M. The exceeding active groups were inactivated with ethanolamine 1 M. Analytes were prepared as 2-fold dilutions of indicated concentrations after the pilot experiments, and injected at a flow rate of 30 μl/min at 25°C [ 28 ]. The concentrations for YFV NS5 ranged from 0.156 to 80 μM, and YFV NS5-RdRp from 0.195 to 100 μM in dilution of PBS containing 5% DMSO.…”